We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer.
- Authors
Lee, Se-Hoon; Ahn, Yong Chan; Kim, Ho Joong; Lim, Do Hoon; Lee, Soon Il; Nam, Eunmi; Park, Se Hoon; Park, Jinny; Lee, Kyung-Eun; Park, Joon Oh; Kim, Kihyun; Kim, Won Seog; Jung, Chul Won; Im, Young-Hyuck; Kang, Won Ki; Lee, Mark H.; Park, Keunchil
- Abstract
Background: Combined chemoradiotherapy (CRT) is the standard treatment modality for limited-stage small-cell lung cancer (LSCLC), but the optimal timing of radiation is controversial. Prolonged oral etoposide has the advantage of prolonged exposure, which possibly leads to improved clinical outcome. We conducted a phase II trial of early concurrent CRT, starting from the very beginning of the first cycle of chemotherapy for previously untreated LSCLC.
- Publication
Japanese Journal of Clinical Oncology, 2003, Vol 33, Issue 12, p620
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyg115